Agenda I position absolutely increases the volume of complexity for just about any research review. For example, all researchers—no matter whether preclinical or clinical—ought to acquire Routine I exploration registrations. 21 CFR section 1301.18. In contrast, researchers which have DEA Practitioner registrations in Schedules II–V (which mos